세계의 리스페리돈 시장 보고서(2025년)

Risperidone is an atypical antipsychotic medication used to manage mental health disorders such as schizophrenia, bipolar disorder, and irritability linked to autism. It functions by balancing key neurotransmitters in the brain, particularly dopamine and serotonin, to improve mood, thought processes, and behavior.

The primary product types of risperidone are tablets, oral solution, and injectable. Tablets are an oral form of risperidone used to treat conditions such as schizophrenia, bipolar disorder, and irritability associated with autism by helping regulate neurotransmitter activity in the brain. Risperidone is administered across different patient groups, including pediatric, adult, and elderly populations. It is applied in therapeutic areas such as schizophrenia, bipolar disorder, autism, and other related conditions. Distribution occurs through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, and clinic pharmacies, serving end users such as hospitals, homecare, specialty clinics, ambulatory surgical centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The risperidone market research report is one of a series of new reports from The Business Research Company that provides risperidone market statistics, including the risperidone industry's global market size, regional shares, competitors with a risperidone market share, detailed risperidone market segments, market trends and opportunities, and any further data you may need to thrive in the risperidone industry. This risperidone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The risperidone market size has grown strongly in recent years. It will grow from $7.13 billion in 2024 to $7.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period was driven by the increasing prevalence of schizophrenia and bipolar disorder, rising awareness of mental health conditions, greater adoption of atypical antipsychotics over conventional drugs, expansion of psychiatric clinics and hospitals, and the growing number of geriatric populations prone to psychiatric conditions.

The risperidone market size is expected to see strong growth in the next few years. It will grow to $10.35 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth during the forecast period is fueled by rising demand for long acting injectable formulations, increasing incidence of pediatric and adolescent psychiatric disorders, greater focus on personalized medicine in psychiatry, wider use of risperidone in combination therapies, and expanding healthcare expenditure in emerging markets. The primary trends in the forecast period include the development of combination therapies, integration with digital health platforms, adoption in telepsychiatry services, innovation in delivery methods, and the introduction of cost effective generics.

The rising prevalence of mental health disorders is expected to drive the growth of the risperidone market. Mental health disorders encompass a wide range of conditions that affect mood, thinking, and behavior, leading to significant distress and disruption in daily functioning. The increasing rates of these disorders are largely due to heightened stress levels and changes in modern lifestyles, which affect emotional balance, sleep patterns, and overall mental well-being. Risperidone is commonly used to manage mental health conditions by regulating neurotransmitters in the brain, which helps reduce symptoms such as agitation, hallucinations, and mood swings, thus promoting emotional stability. For example, in March 2024, the House of Commons Library reported a rise in mental health disorders among 17- to 19-year-olds, with the proportion increasing from 17% in 2021 to 26% in 2022. As mental health issues continue to grow, the demand for risperidone is expected to increase.

Companies in the risperidone market are focusing on developing advanced treatment solutions, such as long-acting injectable formulations, to enhance patient adherence and improve treatment outcomes. Long-acting injectables are medications designed to release risperidone gradually over time, requiring less frequent dosing while maintaining consistent therapeutic effects. For example, in January 2023, Luye Pharma Group Ltd., a pharmaceutical company based in China, received approval from the U.S. Food and Drug Administration (FDA) for Rykindo (risperidone), an extended-release injectable formulation. This treatment is used for managing schizophrenia and as adjunctive therapy with lithium or valproate in the maintenance treatment of bipolar I disorder in adults. The biweekly intramuscular injection is developed using Luye Pharma's microsphere technology, allowing for sustained release to maintain symptom control. The formulation offers rapid symptom relief and flexibility for physicians to adjust treatment based on patient needs, improving overall treatment adherence.

In January 2025, Lyndra Therapeutics Inc., a clinical-stage biopharmaceutical company based in the U.S., partnered with Thermo Fisher Scientific to advance long-acting oral therapies, including weekly oral risperidone. This partnership is aimed at transforming the way patients take their medication, by enabling the large-scale manufacturing and clinical trial support necessary to bring long-acting oral therapies, such as weekly oral risperidone, to broader markets. Thermo Fisher Scientific is a leading company in the production of risperidone and will support Lyndra Therapeutics in developing innovative oral therapies to improve patient compliance and treatment outcomes.

Major players in the risperidone market are Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Zydus Cadila Healthcare Ltd, Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Natco Pharma Limited., Strides Pharma Science Limited., RPG Life Sciences Limited., Jubilant Cadista Pharmaceuticals Inc., ICROM S.p.A., Accord Healthcare Ltd., Ambica Pharma Machines Pvt. Ltd., Gonane Pharma Private Limited., Janssen Pharmaceuticals, LGM Pharma.

North America was the largest region in the risperidone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in risperidone report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the risperidone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The risperidone market consists of sales of orally disintegrating tablets, oral syrups, injectable long-acting formulations, combination formulations, and extended-release tablets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Risperidone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on risperidone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for risperidone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The risperidone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Oral Solution; Injectable
• 2) By Patient Age Group: Pediatric Patients; Adult Patients; Elderly Patients
• 3) By Application: Schizophrenia; Bipolar Disorder; Autism; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Clinic Pharmacies
• 5) By End-Users: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Tablets: Standard Release; Extended Release; Orally Disintegrating
• 2) By Oral Solution: Flavored Solution; Unflavored Solution; Concentrated Solution
• 3) By Injectable: Long Acting Injection; Short Acting Injection; Depot Injection
• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Cipla Limited.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals PLC; Zydus Cadila Healthcare Ltd; Alkem Laboratories Ltd.; Amneal Pharmaceuticals LLC; Natco Pharma Limited.; Strides Pharma Science Limited.; RPG Life Sciences Limited.; Jubilant Cadista Pharmaceuticals Inc.; ICROM S.p.A.; Accord Healthcare Ltd.; Ambica Pharma Machines Pvt. Ltd.; Gonane Pharma Private Limited.; Janssen Pharmaceuticals; LGM Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Risperidone Market Characteristics

3. Risperidone Market Trends And Strategies

4. Risperidone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Risperidone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Risperidone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Risperidone Market Growth Rate Analysis
• 5.4. Global Risperidone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Risperidone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Risperidone Total Addressable Market (TAM)

6. Risperidone Market Segmentation

• 6.1. Global Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Oral Solution
• Injectable
• 6.2. Global Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Patients
• Adult Patients
• Elderly Patients
• 6.3. Global Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Schizophrenia
• Bipolar Disorder
• Autism
• Other Applications
• 6.4. Global Risperidone Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Clinic Pharmacies
• 6.5. Global Risperidone Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.6. Global Risperidone Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Release
• Extended Release
• Orally Disintegrating
• 6.7. Global Risperidone Market, Sub-Segmentation Of Oral Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flavored Solution
• Unflavored Solution
• Concentrated Solution
• 6.8. Global Risperidone Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long Acting Injection
• Short Acting Injection
• Depot Injection

7. Risperidone Market Regional And Country Analysis

• 7.1. Global Risperidone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Risperidone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Risperidone Market

• 8.1. Asia-Pacific Risperidone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Risperidone Market

• 9.1. China Risperidone Market Overview
• 9.2. China Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Risperidone Market

• 10.1. India Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Risperidone Market

• 11.1. Japan Risperidone Market Overview
• 11.2. Japan Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Risperidone Market

• 12.1. Australia Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Risperidone Market

• 13.1. Indonesia Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Risperidone Market

• 14.1. South Korea Risperidone Market Overview
• 14.2. South Korea Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Risperidone Market

• 15.1. Western Europe Risperidone Market Overview
• 15.2. Western Europe Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Risperidone Market

• 16.1. UK Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Risperidone Market

• 17.1. Germany Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Risperidone Market

• 18.1. France Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Risperidone Market

• 19.1. Italy Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Risperidone Market

• 20.1. Spain Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Risperidone Market

• 21.1. Eastern Europe Risperidone Market Overview
• 21.2. Eastern Europe Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Risperidone Market

• 22.1. Russia Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Risperidone Market

• 23.1. North America Risperidone Market Overview
• 23.2. North America Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Risperidone Market

• 24.1. USA Risperidone Market Overview
• 24.2. USA Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Risperidone Market

• 25.1. Canada Risperidone Market Overview
• 25.2. Canada Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Risperidone Market

• 26.1. South America Risperidone Market Overview
• 26.2. South America Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Risperidone Market

• 27.1. Brazil Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Risperidone Market

• 28.1. Middle East Risperidone Market Overview
• 28.2. Middle East Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Risperidone Market

• 29.1. Africa Risperidone Market Overview
• 29.2. Africa Risperidone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Risperidone Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Risperidone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Risperidone Market Competitive Landscape And Company Profiles

• 30.1. Risperidone Market Competitive Landscape
• 30.2. Risperidone Market Company Profiles
  • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sandoz International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cipla Limited. Overview, Products and Services, Strategy and Financial Analysis

31. Risperidone Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories Ltd.
• 31.2. Hikma Pharmaceuticals PLC
• 31.3. Zydus Cadila Healthcare Ltd
• 31.4. Alkem Laboratories Ltd.
• 31.5. Amneal Pharmaceuticals LLC
• 31.6. Natco Pharma Limited.
• 31.7. Strides Pharma Science Limited.
• 31.8. RPG Life Sciences Limited.
• 31.9. Jubilant Cadista Pharmaceuticals Inc.
• 31.10. ICROM S.p.A.
• 31.11. Accord Healthcare Ltd.
• 31.12. Ambica Pharma Machines Pvt. Ltd.
• 31.13. Gonane Pharma Private Limited.
• 31.14. Janssen Pharmaceuticals
• 31.15. LGM Pharma

32. Global Risperidone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Risperidone Market

34. Recent Developments In The Risperidone Market

35. Risperidone Market High Potential Countries, Segments and Strategies

• 35.1 Risperidone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Risperidone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Risperidone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer